{"id":"W2919228285","doi":"10.1080/13696998.2019.1590842","title":"Cost-effectiveness of second-line atezolizumab in Canada for advanced non-small cell lung cancer (NSCLC)","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Western University; University of Alberta; William Osler Health System; Roche (Canada)","funders":"","keywords":"Atezolizumab; Docetaxel; Medicine; Nivolumab; Oncology; Lung cancer; Cost effectiveness; Clinical trial; Internal medicine; Chemotherapy; Cancer; Immunotherapy; Risk analysis (engineering)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001016891,0.0001269603,0.0006886596,0.0001012696,0.00001137971,0.000004639623,0.0001997199,0.0001213333,0.0006998919],"category_scores_gemma":[0.00005819727,0.000105929,0.0001705418,0.00007191711,0.0000333558,0.00006960239,0.00002171989,0.0003016637,5.542178e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001482991,"about_ca_system_score_gemma":0.007726778,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.05542929,"about_ca_topic_score_gemma":0.3044696,"domain_scores_codex":[0.9986449,0.00003585306,0.000767669,0.0001371978,0.0001903925,0.0002240018],"domain_scores_gemma":[0.9986664,0.0003939624,0.0004849074,0.0001386641,0.0001199679,0.0001961028],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1135269,0.001469013,0.3815358,0.01485412,0.002774268,0.000328469,0.001595815,0.01313403,0.05984981,0.0001365995,0.006045258,0.4047499],"study_design_scores_gemma":[0.2410408,0.006110345,0.3572166,0.01453004,0.0006625064,0.0006516216,0.003787612,0.0594526,0.2374733,0.0001854863,0.07747146,0.001417564],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947087,0.002002293,0.0002119279,0.0008115357,0.001273019,0.0007304531,0.00004312234,0.000001394934,0.0002175855],"genre_scores_gemma":[0.9967727,0.002047252,0.0002012205,0.0006788218,0.0001637637,0.00001144327,0.000005662936,0.00002120738,0.00009794971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4033324,"threshold_uncertainty_score":0.9978985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01627561786555592,"score_gpt":0.2918249683696434,"score_spread":0.2755493505040875,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}